» Articles » PMID: 30260458

The Effect of Reducing the "Jumping to Conclusions" Bias on Treatment Decision-Making Capacity in Psychosis: A Randomized Controlled Trial With Mediation Analysis

Overview
Journal Schizophr Bull
Specialty Psychiatry
Date 2018 Sep 28
PMID 30260458
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Evidence-based psychological interventions to support treatment decision-making capacity (capacity) in psychosis do not currently exist. This study sought to establish whether reducing the extent to which this group form conclusions based on limited evidence, also known as the "jumping-to-conclusions" (JTC) bias, could improve capacity.

Methods: In a randomized controlled open trial, 37 patients aged 16-65 years diagnosed with schizophrenia-spectrum disorders were randomly assigned (1:1) to receive a single-session intervention designed to reduce the JTC bias (MCT-JTC; adapted from Metacognitive Training [MCT]) or an attention control (AC) condition designed to control for therapist attention, duration, modality, and face validity. Primary outcomes were treatment decision-making capacity measured by the MacArthur Competency Assessment Tool for Treatment (MacCAT-T) and the jumping-to-conclusions reasoning bias measured by draws to decision on the beads task, each of which were administered by the psychologist delivering the intervention.

Results: Those receiving MCT-JTC had large improvements in overall capacity (d = 0.96, P < .05) and appreciation (d = 0.87, P < .05) compared to those receiving AC. Reduction in JTC mediated a large proportion of the effect of group allocation on understanding, appreciation, reasoning, and overall MacCAT-T scores.

Conclusion: This is the first experimental investigation of the effect of a psychological intervention on treatment decision-making capacity in psychosis. It provides early evidence that reducing the JTC bias is associated with large and rapid improvements in capacity. Due to limited resources, assessments were administered by the researchers delivering the intervention. Results should therefore be considered preliminary and a larger, definitive trial addressing methodological limitations is warranted.

Citing Articles

Accelerating the development of a psychological intervention to restore treatment decision-making capacity in patients with schizophrenia-spectrum disorder: a study protocol for a multi-site, assessor-blinded, pilot Umbrella trial (the DEC:IDES....

Hutton P, Kelly J, Taylor C, Williams B, Emsley R, Alexander C Pilot Feasibility Stud. 2023; 9(1):117.

PMID: 37422659 PMC: 10329297. DOI: 10.1186/s40814-023-01323-0.


Effects of Integrated Moral Reasoning Development Intervention for Management of Violence in Schizophrenia: A Randomized Controlled Trial.

Hsu M, Ouyang W J Clin Med. 2022; 11(5).

PMID: 35268258 PMC: 8911519. DOI: 10.3390/jcm11051169.


Relationship between jumping to conclusions and clinical outcomes in people at clinical high-risk for psychosis.

Catalan A, Tognin S, Kempton M, Stahl D, Salazar de Pablo G, Nelson B Psychol Med. 2020; 52(8):1569-1577.

PMID: 33019957 PMC: 9226382. DOI: 10.1017/S0033291720003396.

References
1.
White I, Carpenter J, Horton N . Including all individuals is not enough: lessons for intention-to-treat analysis. Clin Trials. 2012; 9(4):396-407. PMC: 3428470. DOI: 10.1177/1740774512450098. View

2.
MacKinnon D, Fairchild A, Fritz M . Mediation analysis. Annu Rev Psychol. 2006; 58:593-614. PMC: 2819368. DOI: 10.1146/annurev.psych.58.110405.085542. View

3.
Naughton M, Nulty A, Abidin Z, Davoren M, ODwyer S, Kennedy H . Effects of group metacognitive training (MCT) on mental capacity and functioning in patients with psychosis in a secure forensic psychiatric hospital: a prospective-cohort waiting list controlled study. BMC Res Notes. 2012; 5:302. PMC: 3406956. DOI: 10.1186/1756-0500-5-302. View

4.
Vitzthum F, Veckenstedt R, Moritz S . Individualized metacognitive therapy program for patients with psychosis (MCT+): introduction of a novel approach for psychotic symptoms. Behav Cogn Psychother. 2013; 42(1):105-10. DOI: 10.1017/S1352465813000246. View

5.
Higgins J, Altman D, Gotzsche P, Juni P, Moher D, Oxman A . The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011; 343:d5928. PMC: 3196245. DOI: 10.1136/bmj.d5928. View